Status | Study |
Active, not recruiting |
Study Name: The Synergy Trial: Methylphenidate Plus a CFS-Specific Nutrient Formula as a Treatment for Chronic Fatigue Syndrome Condition: Chronic Fatigue Syndrome (CFS) Myalgic Encephalomyelitis (ME) Date: 2013-10-14 Interventions: Drug: Methyl-P plus Nutrient Formula |
Terminated |
Study Name: Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome Condition: Chronic Fatigue Syndrome Myalgic Encephalomyelitis Date: 2012-11-08 Interventions: Drug: Etanercept Weekly subcutaneous injections of Etanercept 50 mg, for up to 12 months. |
Completed |
Study Name: Western Equine Encephalitis Vaccine Condition: Virus Date: 2010-07-08 Interventions: Biological: Western Equine Encephalitis Vaccine Subject will be vaccinated with 0.5 mL of reconstituted |
Terminated |
Study Name: B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome Condition: Chronic Fatigue Syndrome Myalgic Encephalomyelitis Date: 2010-07-02 Interventions: Drug: Rituximab Two infusions of Rituximab 500 mg/m2 (max |
Completed |
Study Name: B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome Condition: Chronic Fatigue Syndrome Myalgic Encephalomyelitis Date: 2010-07-02 Interventions: Drug: Rituximab Two infusions of Rituximab 500 mg/m2 (max |
Completed |
Study Name: The Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology and Intervention Trial Condition: Chronic Fatigue Syndrome Myalgic Encephalomyelitis Date: 2009-12-28 Interventions: Drug: Clonidine |
Terminated |
Study Name: Pilot Study of Alternative Treatments of Unexplained Chronic Fatigue Condition: Idiopathic Chronic Fatigue Chronic Fatigue Syndrome Myalgi Date: 2009-09-22 |
Completed |
Study Name: Survey and Cognitive Behavior Therapy for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Condition: Chronic Fatigue Syndrome Myalgic Encephalomyelitis Date: 2009-06-12 Interventions: Behavioral: CBT Individual Cog |
Enrolling by invitation |
Study Name: Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine Condition: Venezuelan Equine Encephalomyelitis Date: 2007-12-19 Interventions: Biological: VEE TC-83 Subjects will receive a single 0.5 mL dose by subcutaneous route in the upper oute |
Suspended |
Study Name: Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83 Condition: Venezuelan Equine Encephalomyelitis Date: 2007-12-19 Interventions: Biological: VEE C-84 Subjects will receive a 0.5 mL subcutaneous injection in the upper outer aspect of |